CHOLESTATIC LIVER DISEASES

Protective and aggressive bacterial subsets and metabolites modify hepatobiliary inflammation and fibrosis in a murine model of PSC
Muyiwa Awoniyi, Jeremy Wang, Billy Ngo, Vik Meadows, Jason Tam, Amba Viswanathan, Yunjia Lai, Stephanie Montgomery, Morgan Farmer, Martin Kummen, Louise Thingholm, Christoph Schramm, Corinna Bang, Andre Franke, Kun Lu, Huiping Zhou, Jasmohan S Bajaj, Phillip B Hylemon, Jenny Ting, Yury V Popov, Johannes Roksund Hov, Heather L Francis, Ryan Balfour Sartor

Gut Jun 2022, gutjnl-2021-326500; DOI: 10.1136/gutjnl-2021-326500
Sodium⁺/taurocholate cotransporting polypeptide as target therapy for liver fibrosis
Ahmad Salhab, Johnny Amer, Yinying Lu, Rifaat Safadi

Gut Jul 2022, 71 (7) 1373-1385; DOI: 10.1136/gutjnl-2020-323345
Effect of scheduled endoscopic dilatation of dominant strictures on outcome in patients with primary sclerosing cholangitis
Christian Rupp, Theresa Hippchen, Thomas Bruckner, Petra Klöters-Plachky, Anja Schaible, Ronald Koschny, Adolf Stiehl, Daniel Nils Gotthardt, Peter Sauer

Gut Dec 2019, 68 (12) 2170-2178; DOI: 10.1136/gutjnl-2018-316801
Oesophageal and scaly skin lesions associated with chronic cholestatic liver disease
Philipp Kasper, Tobias Goeser, Dirk Nierhoff

Gut Nov 2019, 68 (11) 1960-2018; DOI: 10.1136/gutjnl-2019-318502
Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis
Lijun Liao, Kai Markus Schneider, Eric J C Galvez, Mick Frissen, Hanns-Ulrich Marschall, Huan Su, Maximilian Hatting, Annika Wahlström, Johannes Haybaeck, Philip Puchas, Antje Mohs, Jin Peng, Ina Bergheim, Anika Nier, Julia Hennings, Johanna Reißing, Henning W Zimmermann, Thomas Longerich, Till Strowig, Christian Liedtke, Francisco J Cubero, Christian Trautwein

Gut Aug 2019, 68 (8) 1477-1492; DOI: 10.1136/gutjnl-2018-316670
Manipulation of the gut–liver axis by interruption of bile acid recirculation: an option for the treatment of sclerosing cholangitis?
Daniel Jahn, Marco Marzioni, Andreas Geier

Gut Sep 2018, 67 (9) 1565-1567; DOI: 10.1136/gutjnl-2018-316375
Response to ‘Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis’ by Rühlemann et al
Martin Kummen, Johannes R Hov

Gut Apr 2017, 66 (4) 755-756; DOI: 10.1136/gutjnl-2016-312347
Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis
Malte Christoph Rühlemann, Femke-Anouska Heinsen, Roman Zenouzi, Wolfgang Lieb, Andre Franke, Christoph Schramm

Gut Apr 2017, 66 (4) 753-754; DOI: 10.1136/gutjnl-2016-312180
Pleiotrophin regulates the ductular reaction by controlling the migration of cells in liver progenitor niches
Gregory A Michelotti, Anikia Tucker, Marzena Swiderska-Syn, Mariana Verdelho Machado, Steve S Choi, Leandi Kruger, Erik Soderblom, J Will Thompson, Meredith Mayer-Salman, Heather A Himburg, Cynthia A Moylan, Cynthia D Guy, Katherine S Garman, Richard T Premont, John P Chute, Anna Mae Diehl

Gut Apr 2016, 65 (4) 683-692; DOI: 10.1136/gutjnl-2014-308176
Targeting TGR5 in cholangiocyte proliferation: default topic
Cecília M P Rodrigues, Han Moshage

Gut Mar 2016, 65 (3) 369-370; DOI: 10.1136/gutjnl-2015-310812

Main menu

CHOLESTATIC LIVER DISEASES

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

CHOLESTATIC LIVER DISEASES

Pages